139 related articles for article (PubMed ID: 16361125)
41. Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphoma.
Nakahara T; Takagi Y; Shiga H; Uchida H; Kaburaki J; Kubo A
Clin Nucl Med; 2007 Feb; 32(2):87-9. PubMed ID: 17242558
[TBL] [Abstract][Full Text] [Related]
42. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
Juweid ME; Stroobants S; Hoekstra OS; Mottaghy FM; Dietlein M; Guermazi A; Wiseman GA; Kostakoglu L; Scheidhauer K; Buck A; Naumann R; Spaepen K; Hicks RJ; Weber WA; Reske SN; Schwaiger M; Schwartz LH; Zijlstra JM; Siegel BA; Cheson BD;
J Clin Oncol; 2007 Feb; 25(5):571-8. PubMed ID: 17242397
[TBL] [Abstract][Full Text] [Related]
43. Is MRI less accurate than FDG-PET/CT in diagnosing bone marrow involvement in lymphoma?
Kwee TC; Nievelstein RA
Eur J Radiol; 2011 Nov; 80(2):565-6. PubMed ID: 21237596
[No Abstract] [Full Text] [Related]
44. [Lymphoma in the peripheral nerves and muscles].
Oya Y
Brain Nerve; 2014 Aug; 66(8):955-67. PubMed ID: 25082317
[TBL] [Abstract][Full Text] [Related]
45. Lymphoma imaging: nuclear medicine.
Kostakoglu L; Goldsmith SJ
Cancer Treat Res; 2006; 131():363-412. PubMed ID: 16704177
[No Abstract] [Full Text] [Related]
46. Reply to G. Keramida et al.
Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller S; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cheson BD
J Clin Oncol; 2015 Dec; 33(34):4121-2. PubMed ID: 26304890
[No Abstract] [Full Text] [Related]
47. A 66-year-old patient with progressive left hemiparesis: question.
Lotan I; Djaldetti R; Luckman J; Siegal T; Steiner I
J Clin Neurosci; 2014 Nov; 21(11):1966, 2031. PubMed ID: 25587611
[No Abstract] [Full Text] [Related]
48. Double image. Adding PET/MR systems into the imaging unit mix.
DiDonato S
Health Facil Manage; 2013 Aug; 26(8):26-8. PubMed ID: 24069704
[No Abstract] [Full Text] [Related]
49. MRI-and CT-scopic microsurgery and drug installation for outpatient treatments.
Grönemeyer DH; Seibel RM
Stud Health Technol Inform; 1996; 29():77-9. PubMed ID: 10172837
[No Abstract] [Full Text] [Related]
50. Report from the opening of a new PET-CT-NMR centre in Cracow, Poland, June 10, 2011.
Dziuk E
Nucl Med Rev Cent East Eur; 2011; 14(2):124. PubMed ID: 22219157
[No Abstract] [Full Text] [Related]
51. Monitoring lymphoma patients after therapy.
Roschewski M
Clin Adv Hematol Oncol; 2015 May; 13(5):277-9. PubMed ID: 26352768
[No Abstract] [Full Text] [Related]
52. Role of routine imaging in lymphoma.
Wagner-Johnston ND; Bartlett NL
J Natl Compr Canc Netw; 2011 May; 9(5):575-84; quiz 585. PubMed ID: 21550970
[TBL] [Abstract][Full Text] [Related]
53. Mobile imaging defies critics by continuing to roll along.
Lindahl RM
Diagn Imaging (San Franc); 1999 Apr; 21(4):44-5, 48. PubMed ID: 10537788
[No Abstract] [Full Text] [Related]
54. Role of MRI bone marrow imaging in recurrent lymphoma.
Graeb D
Can Assoc Radiol J; 1990 Feb; 41(1):51. PubMed ID: 2310964
[No Abstract] [Full Text] [Related]
55. Evolution of lymphoma staging and response evaluation: current limitations and future directions.
Cunningham J; Iyengar S; Sharma B
Nat Rev Clin Oncol; 2017 Oct; 14(10):631-645. PubMed ID: 28607514
[TBL] [Abstract][Full Text] [Related]
56. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: II. Basic knowledge of lymphoid malignancies; 2. Imaging studies in lymphoma].
Izutsu K
Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1794-800. PubMed ID: 21863755
[No Abstract] [Full Text] [Related]
57. Improved Visualization of Lymphomatous Cardiac Involvement with Retrospective PET/MRI Fusion.
Hunter JG; Gad M; Gupta A
Radiol Imaging Cancer; 2023 Nov; 5(6):e230073. PubMed ID: 37830923
[No Abstract] [Full Text] [Related]
58. Anaesthesia for magnetic resonance imaging and positron emission tomography.
Veenith T; Coles JP
Curr Opin Anaesthesiol; 2011 Aug; 24(4):451-8. PubMed ID: 21577098
[TBL] [Abstract][Full Text] [Related]
59. Response criteria for malignant lymphoma.
Maffione AM; Paolini R; Rodella E; Ambrosio C; Rampin L; Lisato LC; Ballotta M; Pavanato G; Rubello D
Nucl Med Commun; 2015 Apr; 36(4):398-405. PubMed ID: 25603273
[TBL] [Abstract][Full Text] [Related]
60. [Response criteria for malignant lymphoma].
Ganten MK
Radiologe; 2012 Apr; 52(4):330-7. PubMed ID: 22418972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
